IL6 and neoplasm: Although IL6 mRNA levels were not associated with clinical and tumor features (Supplementary Table 1 and Supplementary Figure 1), patients with high tumor IL6 expression showed a median overall survival (OS) of 6.97 months in comparison with a median OS of 15.5 months among patients with low IL6 expression (Figure 1C).